Table III.
95.0% confidence interval | ||||
---|---|---|---|---|
Factor | P-value | Hazard ratio | Inferior | Superior |
KRAS mutation | 0.001 | 2.484 | 1.472 | 4.192 |
Resection/local treatment of hepatic metastases | 0.024 | 0.447 | 0.222 | 0.901 |
T4 stage | 0.034 | 1.795 | 1.045 | 3.084 |
ECOG Performance 1-2 | 0.003 | 1.632 | 1.182 | 2.254 |
ECOG, Eastern Cooperative Oncology Group performance status.